PRECLINICAL
RESEARCH
GLP preclinical research, tailored for the medical device & pharmaceutical industries
In the heart of North Carolina’s booming Research Triangle, Synchrony Labs was founded over 40 years ago by cardiology leaders at Duke University Medical School. The first breakthrough to be developed, refined and tested at Synchrony was a transformative, bioabsorbable, drug eluting stent. In the decades since, our pristine, deeply resourced labs have been providing exceptional GLP preclinical research services for leaders, innovators and entrepreneurs in the medical device and pharmaceutical industries.
When Synchrony Labs was established, we laid a strong foundation based on clear principles:
• GLP compliance is paramount
• Data integrity must be secure
• Be flexible as needed
• Deadlines are critical
• Budgets should be respected
• Communicate and collaborate
As a result, Synchrony Labs has worked closely with hundreds of clients advancing life changing medical science. Managing large experimental models is a particular specialty.
Our team is composed of seasoned veterinarians, physicians, interventional specialists, data scientists, and research professionals. They drive innovative preclinical trials by synchronizing our expertise, passion and commitment to create a brighter future for patients and healthcare professionals worldwide.
